220 related articles for article (PubMed ID: 1730031)
1. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
Lijnen HR; Van Hoef B; Matsuo O; Collen D
Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of fibrin-specific plasminogen activation by staphylokinase.
Lijnen HR; Van Hoef B; De Cock F; Okada K; Ueshima S; Matsuo O; Collen D
J Biol Chem; 1991 Jun; 266(18):11826-32. PubMed ID: 2050679
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
[TBL] [Abstract][Full Text] [Related]
4. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
[TBL] [Abstract][Full Text] [Related]
5. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
Silence K; Collen D; Lijnen HR
J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
[TBL] [Abstract][Full Text] [Related]
6. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
Silence K; Collen D; Lijnen HR
Blood; 1993 Aug; 82(4):1175-83. PubMed ID: 7688990
[TBL] [Abstract][Full Text] [Related]
7. Interaction of staphylokinase with different molecular forms of plasminogen.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
Sakai M; Watanuki M; Matsuo O
Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
10. Staphylokinase: fibrinolytic properties and current experience in patients with occlusive arterial thrombosis.
Collen D; Lijnen HR; Vanderschueren S
Verh K Acad Geneeskd Belg; 1995; 57(3):183-96; discussion 196-8. PubMed ID: 7483814
[TBL] [Abstract][Full Text] [Related]
11. Synergy of in vitro thrombolytic action of combinations of recombinant staphylokinase and single-chain urokinase-type plasminogen activator.
Aisina RB; Moukhametova LI; Varfolomeyev SD
Biochemistry (Mosc); 2003 Nov; 68(11):1252-60. PubMed ID: 14640969
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the murine plasma fibrinolytic system.
Lijnen HR; van Hoef B; Beelen V; Collen D
Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
[TBL] [Abstract][Full Text] [Related]
13. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
Anonick PK; Gonias SL
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
[TBL] [Abstract][Full Text] [Related]
14. alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activator.
Sazonova IY; Robinson BR; Gladysheva IP; Castellino FJ; Reed GL
J Biol Chem; 2004 Jun; 279(24):24994-5001. PubMed ID: 15069059
[TBL] [Abstract][Full Text] [Related]
15. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin.
Sakharov DV; Lijnen HR; Rijken DC
J Biol Chem; 1996 Nov; 271(44):27912-8. PubMed ID: 8910391
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody directed against the high-affinity lysine-binding site (LBS) of human plasminogen. Role of LBS in the regulation of fibrinolysis.
Holvoet P; Lijnen HR; Collen D
Eur J Biochem; 1986 May; 157(1):65-9. PubMed ID: 2940088
[TBL] [Abstract][Full Text] [Related]
17. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
[TBL] [Abstract][Full Text] [Related]
18. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
Schneider M; Nesheim M
J Biol Chem; 2004 Apr; 279(14):13333-9. PubMed ID: 14715655
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
Angles-Cano E; Rouy D; Lijnen HR
Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of staphylokinase, streptokinase and tissue-type plasminogen activator on the lysis of retracted human plasma clots and fibrinolytic plasma parameters in vitro.
Hauptmann J; Glusa E
Blood Coagul Fibrinolysis; 1995 Sep; 6(6):579-83. PubMed ID: 7578902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
